- Home
- NA vs SRTS Comparison
NA vs SRTS Comparison
Compare NA & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NA
- SRTS
- Stock Information
- Founded
- NA 2019
- SRTS 2010
- Country
- NA China
- SRTS United States
- Employees
- NA N/A
- SRTS N/A
- Industry
- NA Semiconductors
- SRTS Medical/Dental Instruments
- Sector
- NA Technology
- SRTS Health Care
- Exchange
- NA Nasdaq
- SRTS Nasdaq
- Market Cap
- NA 97.2M
- SRTS 88.7M
- IPO Year
- NA 2022
- SRTS 2016
- Fundamental
- Price
- NA $5.27
- SRTS $4.43
- Analyst Decision
- NA
- SRTS Strong Buy
- Analyst Count
- NA 0
- SRTS 3
- Target Price
- NA N/A
- SRTS $13.00
- AVG Volume (30 Days)
- NA 17.0K
- SRTS 240.1K
- Earning Date
- NA 03-21-2025
- SRTS 05-08-2025
- Dividend Yield
- NA N/A
- SRTS N/A
- EPS Growth
- NA N/A
- SRTS 1266.06
- EPS
- NA N/A
- SRTS 0.41
- Revenue
- NA $6,991,446.00
- SRTS $41,807,000.00
- Revenue This Year
- NA N/A
- SRTS $9.09
- Revenue Next Year
- NA N/A
- SRTS $22.30
- P/E Ratio
- NA N/A
- SRTS $10.87
- Revenue Growth
- NA N/A
- SRTS 71.31
- 52 Week Low
- NA $2.75
- SRTS $3.09
- 52 Week High
- NA $23.50
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- NA 39.20
- SRTS 35.32
- Support Level
- NA $5.01
- SRTS $4.33
- Resistance Level
- NA $5.32
- SRTS $4.75
- Average True Range (ATR)
- NA 0.67
- SRTS 0.27
- MACD
- NA -0.05
- SRTS 0.03
- Stochastic Oscillator
- NA 16.33
- SRTS 10.09
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.